Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain

C Toth - Therapeutic advances in drug safety, 2014 - journals.sagepub.com
Used mainly for the management of neuropathic pain, pregabalin is a gabapentinoid or
anticonvulsant that was initially developed as an antiepileptic agent. After more than a …

Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature

A Vadalouca, E Raptis, E Moka, P Zis, P Sykioti… - Pain …, 2012 - Wiley Online Library
Neuropathic cancer pain (NCP), commonly encountered in clinical practice, may be cancer‐
related, namely resulting from nervous system tumor invasion, surgical nerve damage …

Neuropathic cancer pain: What we are dealing with? How to manage it?

E Esin, S Yalcin - OncoTargets and therapy, 2014 - Taylor & Francis
Cancer pain is a serious health problem, and imposes a great burden on the lives of patients
and their families. Pain can be associated with delay in treatment, denial of treatment, or …

Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double …

DE Moon, DI Lee, SC Lee, SO Song, DM Yoon… - Clinical …, 2010 - Elsevier
BACKGROUND: Clinical trials from various countries have reported the efficacy of
pregabalin for reducing peripheral neuropathic pain. OBJECTIVE: This study assessed the …

Pregabalin prescription for neuropathic pain and fibromyalgia: a descriptive study using administrative database in Japan

M Hirakata, S Yoshida… - Pain Research and …, 2018 - Wiley Online Library
Objective. To assess dose, characteristics, and coprescribed analgesics in patients newly
prescribed pregabalin for neuropathic pain and fibromyalgia in Japan. Methods. Based on …

Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: findings from a cost …

C Pérez, A Navarro, MT Saldaña, X Masramón… - Clinical …, 2010 - Elsevier
Background: Pregabalin and gabapentin are marketed to treat peripheral neuropathic pain,
but head-to-head comparison is lacking. Objectives: The aims of this work were to compare …

Nonsurgical approaches to neuroma management

Y Liu, DS Kao - Hand clinics, 2021 - hand.theclinics.com
Neuropathic pain continues to be a significant problem in the United States, with health care
costs for patients afflicted with neuropathic pain being 3 times higher than a matched control …

DEEP Study: does EQ‐5D‐5L measure the impacts of persistent oro‐facial pain?

J Durham, JG Steele, M Breckons… - Journal of oral …, 2015 - Wiley Online Library
Summary The EQ‐5D‐5L is a generic quality of life (QOL) measure widely used throughout
the world, which has the advantage that it allows health‐state preferences to be elicited. The …

A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings

A Navarro, MT Saldaña, C Pérez, S Torrades, J Rejas - BMC neurology, 2011 - Springer
Abstract Background Neuropathic pain (NeP) is a common symptom of a group of a variety
of conditions, including diabetic neuropathy, trigeminal neuralgia, or postherpetic neuralgia …

Drug safety evaluation of pregabalin

C Toth - Expert opinion on drug safety, 2012 - Taylor & Francis
Introduction: Pregabalin is an anticonvulsant with one known mechanism of action which is
used most specifically in the management of neuropathic pain. Areas covered: The adverse …